Investor Broadwood Partners, L.p.
Manager Neal C. Bradsher
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Broadwood Partners, L.p. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-09-02 13D/A STAA / STAAR Surgical Company 13,545,391 13,545,391
2025-08-08 13D/A STAA / STAAR Surgical Company 13,358,164 13,545,391
2025-04-07 13D/A STAA / STAAR Surgical Company 12,512,944 13,358,164
2025-04-02 13D/A STAA / STAAR Surgical Company 11,979,098 12,512,944
2025-03-03 13D/A STAA / STAAR Surgical Company 10,794,330 11,979,098
2025-02-10 13D/A IMDX / Insight Molecular Diagnostics Inc. 5,079,316 11,560,350
2025-01-28 13D/A LCTX / Lineage Cell Therapeutics, Inc. 42,058,883 57,848,357
2024-11-21 13D/A LCTX / Lineage Cell Therapeutics, Inc. 41,983,883 42,058,883
2024-11-14 13G/A SER / Serina Therapeutics, Inc. 187,871
2024-04-15 13D/A OCX / OncoCyte Corporation 57,131,187 5,079,316
2024-02-08 13D/A LCTX / Lineage Cell Therapeutics, Inc. 35,227,273 41,983,883
2024-01-10 13D/A STAA / STAAR Surgical Company 10,128,744 10,794,330
2023-11-15 13D/A STAA / STAAR Surgical Company 9,495,623 10,128,744
2023-10-10 13D/A STAA / STAAR Surgical Company 8,617,907 9,495,623
2023-04-07 13D/A OCX / OncoCyte Corporation 30,212,899 57,131,187
2022-07-28 13D/A OCX / OncoCyte Corporation 23,774,964 30,212,899
2022-04-15 13D/A OCX / OncoCyte Corporation 17,835,590 23,774,964
2022-03-25 13D/A LCTX / Lineage Cell Therapeutics, Inc. 34,247,167 35,227,273
2021-10-01 13D/A STAA / STAAR Surgical Company 9,026,257 8,617,907
2021-09-24 13D/A OCX / OncoCyte Corporation 17,835,590 17,835,590
2021-06-16 13D/A STAA / STAAR Surgical Company 9,469,991 9,026,257
2021-04-05 13D/A STAA / STAAR Surgical Company 9,925,922 9,469,991
2021-03-16 13D/A LCTX / Lineage Cell Therapeutics, Inc. 33,911,899 34,247,167
2021-02-09 13D/A OCX / OncoCyte Corporation 17,235,590 17,835,590
2021-01-28 13D/A STAA / STAAR Surgical Company 10,821,248 9,925,922
2021-01-22 13D/A OCX / OncoCyte Corporation 12,157,373 17,235,590
2020-08-12 13D/A STAA / STAAR Surgical Company 10,881,079 10,821,248
2019-09-13 13D/A OCX / OncoCyte Corporation 10,157,373 12,157,373
2019-07-02 13D/A OCX / OncoCyte Corporation 9,157,373 10,157,373
2019-03-12 13D/A LCTX / Lineage Cell Therapeutics, Inc. 33,911,899
2019-03-12 13D/A OCX / OncoCyte Corporation 0
2019-02-12 13D/A OCX / OncoCyte Corporation 8,624,040 9,157,373
2018-12-10 13G AGE / AgeX Therapeutics, Inc. 3,003,446
2018-08-10 13D/A STAA / STAAR Surgical Company 10,881,079
2018-03-30 13D/A OCX / OncoCyte Corporation 8,624,040
2017-09-18 13D/A CMRO / Comarco, Inc. 2,365,500
2017-02-17 13D/A LCTX / Lineage Cell Therapeutics, Inc. 27,332,162
2017-02-14 13G/A CYNO / Cynosure, Inc. 1,331,727 1,338,827
2016-11-14 13G CYNO / Cynosure, Inc. 1,331,727
2016-09-08 13D OCX / OncoCyte Corporation 4,170,143
2016-05-27 13D/A STAA / STAAR Surgical Company 10,866,935
2016-05-13 13D OCX / OncoCyte Corporation 4,028,053
2016-03-24 13D/A STAA / STAAR Surgical Company 10,443,570 10,443,570
2016-02-16 13D/A STAA / STAAR Surgical Company 9,649,557 10,443,570
2016-02-02 13D/A STAA / STAAR Surgical Company 9,675,457
2016-01-12 13D/A STAA / STAAR Surgical Company 9,162,556
2015-09-30 13D/A STAA / STAAR Surgical Company 8,643,462
2015-09-16 13D/A LCTX / Lineage Cell Therapeutics, Inc. 20,477,304
2015-06-02 13D/A STAA / STAAR Surgical Company 8,143,482
2014-11-05 13D/A STAA / STAAR Surgical Company 7,173,336
2014-10-08 13D/A LCTX / Lineage Cell Therapeutics, Inc. 18,045,693
2014-08-19 13D/A CMRO / Comarco, Inc. 3,914,136
2014-06-19 13D/A LCTX / Lineage Cell Therapeutics, Inc. 13,615,170
2014-05-05 13D/A LCTX / Lineage Cell Therapeutics, Inc. 12,015,170
2013-12-31 13D/A LCTX / Lineage Cell Therapeutics, Inc. 9,515,170
2013-11-15 13D/A QCOR / 3,056,077
2013-06-27 13G/A PMTI / Palomar Medical Technologies Llc 0
2013-03-29 13D/A LCTX / Lineage Cell Therapeutics, Inc. 8,945,128
2013-02-19 13D/A LCTX / Lineage Cell Therapeutics, Inc. 3,268,682
2013-02-14 13G/A PMTI / Palomar Medical Technologies Llc 2,898,296
2013-01-10 13D/A LCTX / Lineage Cell Therapeutics, Inc. 8,745,128
2012-08-03 13D/A LCTX / Lineage Cell Therapeutics, Inc. 3,268,682
2012-05-22 13D/A QCOR / 3,868,874
2012-05-21 13D/A QCOR / 3,578,660